# Community Healthcare Trust Inc: Form 10-Q for the period ended Mar 31, 2021

- Company: [Community Healthcare Trust Inc](/companies/chct.md) (CIK 1631569)
- Form: 10-Q
- Filed: 2021-05-04
- Accepted by EDGAR: May 4, 2021, 16:52 ET
- Period: 2021-03-31
- Accession: 0001631569-21-000028
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1631569/000163156921000028/chct-20210331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1631569/000163156921000028/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-01-01 to 2021-03-31 | $21.4m | us-gaap:Revenues |
| Interest expense | 3 months, 2021-01-01 to 2021-03-31 | $2.2m | us-gaap:InterestExpense |
| Net income | 3 months, 2021-01-01 to 2021-03-31 | $5.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-01-01 to 2021-03-31 | $0.21 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-01-01 to 2021-03-31 | $0.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-01-01 to 2021-03-31 | 22,809,222 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2021-01-01 to 2021-03-31 | $13.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 3 months, 2021-01-01 to 2021-03-31 | $10.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2021-03-31 | $5.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2021-03-31 | $735.3m | us-gaap:Assets |
| Total liabilities | at 2021-03-31 | $285.2m | us-gaap:Liabilities |
| Long-term debt | at 2021-03-31 | $260.4m | us-gaap:LongTermDebt |
| Shareholders' equity | at 2021-03-31 | $450.1m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 28,702 characters.

### Disclosure Regarding Forward-Looking Statements

*This report and other materials that Community Healthcare Trust Incorporated (the "Company") has filed or may file with the Securities and Exchange Commission, as well as information included in oral statements or other written statements made, or to be made, by management of the Company, contain, or will contain, statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “believes”, “expects”, “may”, “should”, “seeks”, “approximately”, “intends”, “plans”, “estimates”, “anticipates” or other similar words or expressions, including the negative thereof. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. Thus, the Company’s actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, the Company’s ability to refinance existing indebtedness at or prior to maturity on favorable terms, or at all, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract, effects on global and national markets as well as businesses resulting from the COVID-19 pandemic, and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and the Company’s other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this report and the Company undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.*

*The purpose of this Management's Discussion and Analysis ("MD&A") is to provide an understanding of the Company's consolidated financial condition, results of operations and cash. MD&A is provided as a supplement to, and should be read in conjunction with, the Company's Condensed Consolidated Financial Statements and accompanying notes.*

### Overview

References such as "we," "us," "our," and "the Company" mean Community Healthcare Trust Incorporated, a Maryland corporation, and its consolidated subsidiaries.

We were organized in the State of Maryland on March 28, 2014. We are a self-administered, self-managed healthcare real estate investment trust, or REIT, that acquires and owns properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers.

### Trends and Matters Impacting Operating Results

Management monitors factors and trends that it believes are important to the Company and the REIT industry in order to gauge their potential impact on the operations of the Company. Certain of the factors and trends that management believes may impact the operations of the Company are discussed below.

#### Real estate acquisitions

During the first quarter of 2021, the Company acquired six real estate properties totaling approximately 159,000 square feet for an aggregate purchase price of approximately $59.8 million and cash consideration of approximately $60.0 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations through 2036. Concurrent with the acquisitions, the Company entered into a $6.0 million term loan and a revolver loan up to $4.0 million with the tenant on two of these properties. These acquisitions were funded with cash on hand, proceeds from the Company's ATM Program, and proceeds from the Company's Revolving Credit Facility. See Note 4 to the Condensed Consolidated Financial Statements for more details on these acquisitions.

Subsequent to March 31, 2021, the Company acquired one property for a purchase price of approximately $4.2 million and cash consideration of approximately $3.5 million. The property was approximately 90.9% leased with lease expirations through 2028. This acquisition was funded with cash on hand.

#### Acquisition Pipeline

The Company has two properties under definitive purchase agreements for an aggregate expected purchase price of approximately $8.4 million and expected aggregate returns of approximately 9.3%. The Company expects to close on these properties during the second or third quarter of 2021; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close. The Company expects to fund these acquisitions with cash on hand, proceeds from the Company's ATM Program, and proceeds from the Company's Revolving Credit Facility.

#### Asset Held for Sale

Pursuant to the exercise of a purchase option by a tenant, the Company entered into a sales contract to dispose of a medical office building in Haleyville, Alabama during the first quarter of 2021. The Company expects to close on this transaction in the second quarter of 2021 and expects to recognize a gain on the sale. Assets held for sale totaling approximately $1.0 million are included in Other assets, net and Liabilities held for sale totaling $35,000 are included in Other liabilities, net on the Condensed Consolidated Balance Sheet as of March 31, 2021.

#### Leased square footage

As of March 31, 2021, our real estate portfolio was approximately 89.1% leased. During the first three months of 2021, we had expiring or terminated leases related to approximately 7,000 square feet, and we leased or renewed leases relating to approximately 21,000 square feet.

#### COVID-19 pandemic

During 2020, the world was, and continues to be, impacted by the novel coronavirus (COVID-19) pandemic. COVID-19 and measures to prevent its spread impacted many healthcare providers, including some of our tenants. During 2020, some of them were not seeing patients, others saw a reduced number of elective procedures and/or patient visits, while others experienced limited impact, or even saw improved cash flows from either increases in census or government funding.

During 2020, as a result of the pandemic, the Company entered into deferral agreements with 18 tenants, with deferrals representing less than one percent of our annualized rent in the aggregate. Amounts due under the deferral agreements were generally repaid during 2020, however, at March 31, 2021, there was approximately $51,000 remaining to be billed and paid during the remainder of 2021.

### Seasonality

We do not expect our business to be subject to material seasonal fluctuations.

### New Accounting Pronouncements

See Note 1 to the Company’s Condensed Consolidated Financial Statements accompanying this report for information on new accounting standards recently adopted and not yet adopted.

### Results of Operations

The Company's results of operations for the three months ended March 31, 2021 compared to the same period in 2020 have most significantly been impacted by its real estate acquisitions. As of March 31, 2021 and 2020, the Company had investments in real estate properties totaling approximately $801.0 million (including a portion of one property accounted for as a financing lease with a gross amount totaling approximately $3.0 million and one property classified as held for sale with a gross amount totaling approximately $1.1 million) and $641.9 million, respectively.

### Three Months Ended March 31, 2021 Compared to Three Months Ended March 31, 2020

The table below shows our results of operations for the three months ended March 31, 2021 compared to the same period in 2020 and the effect of changes in those results from period to period on our net income.

*(dollars in thousands)*

| REVENUES | Three Months Ended March 31, 2021 | 2020 | Increase (decrease) to Net income $% |  |
| --- | ---: | ---: | ---: | ---: |
| Rental income | $20,780 | $17,428 | $3,352 | 19.2% |
| Other operating interest | 615 | 508 | 107 | 21.1% |
|  | 21,395 | 17,936 | 3,459 | 19.3% |
| **EXPENSES** |  |  |  |  |
| Property operating | 3,729 | 3,343 | (386) | (11.5)% |
| General and administrative | 2,859 | 2,192 | (667) | (30.4)% |
| Depreciation and amortization | 7,225 | 6,059 | (1,166) | (19.2)% |
|  | 13,813 | 11,594 | (2,219) | (19.1)% |
| **INCOME FROM OPERATIONS** | 7,582 | 6,342 | 1,240 | 19.6% |
| Interest expense | (2,229) | (2,249) | 20 | 0.9% |
| Deferred income tax expense | (39) | — | (39) | n/m |
| Other income | 1 | 7 | (6) | (85.7)% |
| **NET INCOME** | $5,315 | $4,100 | $1,215 | 29.6% |

#### n/m - not meaningful

#### Revenues

Revenues increased approximately $3.5 million, or 19.3%, for the three months ended March 31, 2021 compared to the same period in 2020 mainly due to acquisitions of real estate and the issuance of new notes receivable.

#### Expenses

Property operating expenses increased approximately $0.4 million, or 11.5%, for the three months ended March 31, 2021 compared to the same period in 2020 mainly due to acquisitions of real estate.

General and administrative expenses increased approximately $0.7 million, or 30.4%, for the three months ended March 31, 2021 compared to the same period in 2020 due mainly to compensation-related expenses related to new employees and annual salary increases and stock issuances totaling approximately $0.7 million, including the non-cash amortization of non-vested restricted common shares of approximately $0.5 million.

Depreciation and amortization expense increased approximately $1.2 million, or 19.2%, for the three months ended March 31, 2021 compared to the same period in 2020. Acquisitions accounted for an increase of approximately $1.5 million, offset by a decrease of approximately $0.5 million in amortization due to fully amortized real estate lease intangibles which generally have a shorter depreciable life than a building. The remaining increase is generally due to the depreciation of building and tenant improvements.

### Non-GAAP Financial Measures and Key Performance Indicators

Management considers certain non-GAAP financial measures and key performance indicators to be useful supplemental measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. The Company reports Non-GAAP financial measures because these measures are observed by management to also be among the most predominant measures used by the REIT industry and by industry analysts to evaluate REITs. For these reasons, management deems it appropriate to disclose and discuss these Non-GAAP financial measures. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors, as well as reconciliations of those measures to the most directly comparable GAAP financial measure.

The non-GAAP financial measures and key performance indicators presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income, as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs. Management believes that in order to facilitate a clear understanding of the Company's historical consolidated operating results, these measures should be examined in conjunction with net income and cash flows from operations as presented in the Condensed Consolidated Financial Statements and other financial data included elsewhere in this Quarterly Report on Form 10-Q.

### Funds from Operations ("FFO") and Adjusted Funds from Operations ("AFFO")

FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT’s operating performance equal to net income (calculated in accordance with GAAP), excluding gains or losses from the sale of certain real estate assets, gains and losses from change in control, impairment write-downs of certain real estate assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity, plus depreciation and amortization related to real estate properties, and after adjustments for unconsolidated partnerships and joint ventures. NAREIT also provides REITs with an option to exclude gains, losses and impairments of assets that are incidental to the main business of the REIT from the calculation of FFO.

In addition to FFO, the Company presents AFFO and AFFO per share. The Company defines AFFO as FFO, excluding certain expenses related to closing costs of properties acquired accounted for as business combinations and mortgages funded, excluding straight-line rent and the amortization of stock-based compensation, and including or excluding other non-cash items from time to time. AFFO presented herein may not be comparable to similar measures presented by other real estate companies due to the fact that not all real estate companies use the same definition.

Management believes that net income, as defined by GAAP, is the most appropriate earnings measurement. However, management believes FFO, AFFO, FFO per share and AFFO per share provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, primarily depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, impairments and gains or losses from sales of real estate, losses and impairment of incidental assets, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, FFO, AFFO, FFO per share and AFFO per share can facilitate comparisons of operating performance between periods.

The table below reconciles net income to FFO and AFFO for the three months ended March 31, 2021 compared to the same period in 2020.

*(In thousands, excepts per share amounts)*

|  | Three Months Ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Net income | $5,315 | $4,100 |
| Real estate depreciation and amortization | 7,276 | 6,109 |
| FFO | $12,591 | $10,209 |
| Straight-line rent | (838) | (878) |
| Stock-based compensation | 1,558 | 1,019 |
| AFFO | $13,311 | $10,350 |
| FFO per diluted common share | $0.54 | $0.48 |
| AFFO per diluted common share | $0.57 | $0.49 |
| Weighted average common shares outstanding - diluted (1) | 23,500 | 21,310 |

(1) Diluted weighted average common shares outstanding for FFO and AFFO are calculated based on the treasury method, rather than the 2-class method used to calculate earnings per share.

### Net Operating Income ("NOI")

NOI is a key performance indicator. NOI is defined as net income or loss, computed in accordance with GAAP, generated from our total portfolio of properties and other investments before general and administrative expenses, depreciation and amortization expense, gains or loss on the sale of real estate properties or other investments, interest expense, and income tax expense. We believe that NOI provides an accurate measure of operating performance of our operating assets because NOI excludes certain items that are not associated with management of the properties. The Company's use of the term NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing NOI.

The table below reconciles net income to NOI for the three months ended March 31, 2021 compared to the same period in 2020.

*(In thousands)*

|  | Three Months Ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Net income | $5,315 | $4,100 |
| General and administrative | 2,859 | 2,192 |
| Depreciation and amortization | 7,225 | 6,059 |
| Interest expense | 2,229 | 2,249 |
| Deferred income tax expense | 39 | — |
| NOI | $17,667 | $14,600 |

### EBITDAre and Adjusted EBITDAre

The Company uses the NAREIT definition of EBITDA*re* which is net income plus interest expense, income tax expense, and depreciation and amortization, plus losses or minus gains on the disposition of depreciable property, including losses/gains on change of control, plus impairment write-downs of depreciable property and of investments in unconsolidated affiliates caused by a decrease in value of depreciable property in the affiliate, plus or minus adjustments to reflect the entity's share of EBITDA*re* of unconsolidated affiliates and consolidated affiliates with non-controlling interest. The Company also presents Adjusted EBITDA*re* which is EBITDA*re* before non-cash stock-based compensation amortization.

We consider EBITDA*re* and Adjusted EBITDA*re* important measures because they provide additional information to allow management, investors, and our current and potential creditors to evaluate and compare our core operating results and our ability to service debt.

The table below reconciles net income to EBITDA*re* and Adjusted EBITDA*re* for the three months ended March 31, 2021 compared to the same period in 2020.

*(In thousands)*

|  | Three Months Ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Net income | $5,315 | $4,100 |
| Interest expense | 2,229 | 2,249 |
| Depreciation and amortization | 7,225 | 6,059 |
| Deferred income tax expense | 39 | — |
| EBITDAre | $14,808 | $12,408 |
| Non-cash stock-based compensation expense | 1,558 | 1,019 |
| Adjusted EBITDAre | $16,366 | $13,427 |

### Liquidity and Capital Resources

The Company monitors its liquidity and capital resources and relies on several key indicators in its assessment of capital markets for financing acquisitions and other operating activities as needed, including the following:

- Leverage ratios and financial covenants included in our Credit Facility;
- Dividend payout percentage; and
- Interest rates, underlying treasury rates, debt market spreads and equity markets.

The Company uses these indicators and others to compare its operations to its peers and to help identify areas in which the Company may need to focus its attention.

#### Sources and Uses of Cash

The Company derives most of its revenues from its real estate properties. Our rental income represents our primary source of liquidity to fund our dividends, general and administrative expenses, property operating expenses, interest expense on our Credit Facility, and other expenses incurred related to managing our existing portfolio. To the extent additional resources are needed, the Company will fund its investment activity generally through equity or debt issuances either in the public or private markets or through proceeds from our Credit Facility.

The Company expects to meet its liquidity needs through cash on hand, cash flows from operations and cash flows from sources discussed above. The Company believes that its liquidity and sources of capital are adequate to satisfy its cash requirements. The Company cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to the Company in sufficient amounts to meet its liquidity needs.

The Company's Credit Facility, as amended, provides for a $150.0 million Revolving Credit Facility that matures on March 19, 2026 and includes one 12-month option to extend the maturity date, and $250.0 million in Term Loans, as well as an accordion feature which allows borrowings up to a total of $600.0 million, including the ability to add and fund additional term loans. Note 5 to the Condensed Consolidated Financial Statements provides more details on the Company's Credit Facility. At March 31, 2021, the Company had borrowing capacity remaining under the

Revolving Credit Facility of approximately $143.0 million.

The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. Also, the Company’s current financing policy prohibits aggregate debt (secured or unsecured) in excess of 40% of the Company's total capitalization, except for short-term, transitory periods. At March 31, 2021, our debt to total capitalization ratio (debt plus stockholders' equity plus accumulated depreciation) was approximately 31.7%. The Company was in compliance with its financial covenants under its Credit Facility as of March 31, 2021.

The Company also had outstanding at March 31, 2021, a $5.2 million mortgage note payable, secured by one of its properties, with a maturity date in 2024. See Note 5 to the Condensed Consolidated Financial Statements for more details.

#### Subsequent Acquisitions

Subsequent to March 31, 2021, the Company acquired one property for a purchase price of approximately $4.2 million and cash consideration of approximately $3.5 million. The property was approximately 90.9% leased with lease expirations through 2028. This acquisition was funded with cash on hand.

#### Acquisition Pipeline

The Company has two properties under definitive purchase agreements for an aggregate expected purchase price of approximately $8.4 million and expected aggregate returns of approximately 9.3%. The Company expects to close on these properties during the second or third quarter of 2021; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close. The Company expects to fund these acquisitions with cash on hand, proceeds from the Company's ATM Program, and proceeds from the Company's Revolving Credit Facility.

#### Asset Held for Sale

Pursuant to the exercise of a purchase option by a tenant, the Company entered into a sales contract to dispose of a medical office building in Haleyville, Alabama during the first quarter of 2021. The Company expects to close on this transaction in the second quarter of 2021 and expects to recognize a gain on the sale. Assets held for sale totaling approximately $1.0 million are included in Other assets, net and Liabilities held for sale totaling $35,000 are included in Other liabilities, net on the Condensed Consolidated Balance Sheet as of March 31, 2021.

#### Other Contractual Obligations

Subject to Company approval, we may fund or reimburse tenants for tenant improvements, which are allowed for in certain leases, of up to approximately $2.7 million as of March 31, 2021.

The Company has also entered into contracts regarding certain capital expenditures totaling approximately $2.1 million as of March 31, 2021. Reimbursement of these expenditures by our tenants will be determined by each tenant's lease.

The Company has ground lease obligations relating to three properties, with total obligations of approximately $1.5 million with maturities through 2054.

The Company expects to fund these obligations with cash on hand, proceeds from the Company's ATM Program, and proceeds from the Company's Revolving Credit Facility.

#### Automatic Shelf Registration Statement

On November 5, 2019, the Company filed an automatic shelf registration statement on Form S-3 with the Securities and Exchange Commission. The registration statement is for an indeterminate number of securities and is effective for three years. Under this registration statement, the Company has the capacity to offer and sell from time to time various types of securities, including common stock, preferred stock, depository shares, rights, debt securities, warrants and units.

#### Operating Activities

Cash flows provided by operating activities for the three months ended March 31, 2021 and 2020 were approximately $13.5 million and $10.3 million, respectively. Cash flows provided by operating activities were generally provided by contractual rents, net of expenses, on our real estate property portfolio.

#### Investing Activities

Cash flows used in investing activities for the three months ended March 31, 2021 and 2020 were approximately $67.3 million and $35.5 million, respectively. During the three months ended March 31, 2021, the Company invested in 6 properties for an aggregate cash consideration of approximately $60.0 million and funded notes totaling approximately $7.1 million. Also, during the three months ended March 31, 2021, the Company received payments on its notes totaling $0.9 million and funded capital expenditures on its existing portfolio totaling approximately $1.0 million.

During the three months ended March 31, 2020, the Company invested in six properties for an aggregate cash consideration of approximately $36.4 million, acquired a $2.5 million note receivable for $1.8 million, and received payments on its notes receivable totaling $3.3 million. Also, the Company funded capital expenditures on its existing portfolio totaling approximately $0.7 million.

#### Financing Activities

Cash flows provided by financing activities for the three months ended March 31, 2021 and 2020 were approximately $56.9 million and $26.8 million, respectively. During the three months ended March 31, 2021, the Company repaid $26.0 million under its Credit Facility, entered into an amended and restated credit facility in which the Company entered into a $125.0 million, 7-year term loan facility, repaid a $50.0 million term loan facility, and incurred $1.6 million in additional debt issuance costs. The Company also sold shares under its ATM Program and received proceeds of approximately $19.9 million, and paid dividends totaling $10.3 million.

During the three months ended March 31, 2020, the Company borrowed $9.0 million under its Credit Facility, sold shares under its ATM Program and received proceeds of approximately $26.9 million, and paid dividends totaling $9.0 million.

#### Security Deposits

As of March 31, 2021, the Company held approximately $4.2 million in security deposits for the benefit of the Company in the event the obligated tenant fails to perform under the terms of its respective lease. Generally, the Company may, at its discretion and upon notification to the tenant, draw upon the security deposits if there are any defaults under the leases.

#### Dividends

The Company is required to pay dividends to its stockholders at least equal to 90% of its taxable income in order to maintain its qualification as a REIT.

On April 29, 2021, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.43 per share. The dividend is payable on May 28, 2021 to stockholders of record on May 14, 2021. This rate equates to an annualized dividend of $1.72 per share.

The ability of the Company to pay dividends is dependent upon its ability to generate cash flows and to make accretive new investments.

## Market risk

As filed, 1,266 characters.

Our future income, cash flows and fair values relevant to financial instruments are dependent upon prevailing market interest rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. We may use certain derivative financial instruments to manage, or hedge, interest rate risks related to our borrowings. We will not use derivatives for trading or speculative purposes and only enter into contracts with major financial institutions based upon their credit rating and other factors. An interest rate swap is a contractual agreement entered into by two counterparties under which each agrees to make periodic payments to the other for an agreed period of time based on a notional amount of principal. Under the most common form of interest rate swap, known from our perspective as a floating-to-fixed interest rate swap, a series of floating, or variable, rate payments on a notional amount of principal is exchanged for a series of fixed interest rate payments on such notional amount. During the three months ended March 31, 2021, there were no material changes in the quantitative and qualitative disclosures about market risks presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

## Controls and procedures

As filed, 1,031 characters.

### Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.

### Changes In Internal Control Over Financial Reporting

There were no changes in our system of internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 262 characters.

In addition to the other information set forth in this Quarterly Report on Form 10-Q, an investor should consider the risk factors included in its Annual Report on Form 10-K for the year ended December 31, 2020 and other reports that may be filed by the Company.

Filed May 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001631569-21-000028. Last ingested by Listed: Nov 3, 2026, 19:39 ET. No prices; not investment advice.
